Qube Research & Technologies Ltd

Position in CRBU — Caribou Biosciences, Inc.

CIK 1729829 LONDON, X0

Position in CRBU

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$960,528

+$624,804 QoQ

Shares Held

545,755

+208.9% QoQ

Ownership

0.509%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#19

of 137 holders

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. CRBU ranks #119 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$960,528	545,755	+208.9%	Shares	Sole	2026-08-14
2026-03-31	$335,724	176,697	-13.7%	Shares	Sole	2026-05-15
2025-12-31	$325,396	204,652	+353.3%	Shares	Sole	2026-02-17
2025-09-30	$105,199	45,150	-79.5%	Shares	Sole	2025-11-14
2024-06-30	$360,827	220,017	+163.1%	Shares	Sole	2024-08-14
2023-06-30	$355,351	83,612	+248.0%	Shares	Sole	2023-08-14
2022-12-31	$150,877	24,025	+67.7%	Shares	Sole	2023-02-14
2022-06-30	$77,790	14,326	-71.5%	Shares	Sole	2022-08-15
2022-03-31	$461,368	50,258	—	Shares	Sole	2022-05-09
No filing history on record for this holder in this stock.